期刊文献+

妊娠糖尿病孕妇糖化血红蛋白与部分止凝血指标活性的相关性 被引量:2

Correlation between GHbA1c and Coagulative Activity,Fibrinolytic Activity in Patients with Gestational Diabetes Mellitus
原文传递
导出
摘要 目的探讨妊娠糖尿病(GDM)孕妇的部分凝血、纤溶指标活性的变化及其与糖化血红蛋白(GHbA1c)的相关性。方法对正常非孕妇女、正常妊娠妇女(各40例)和GDM孕妇(50例)的GHbA1c、血浆Ⅶc因子(FⅦc)、组织型纤溶酶原激活物(t-PA)及其抑制物(PAI-1)、蛋白C活性依赖凝固时间(PCAT)及抗凝血酶-Ⅲ(AT-Ⅲ)等指标进行检测,并分析糖化血红蛋白与各指标之间的相关性。结果与正常非孕组及正常妊娠组比较,GDM组GHbA1c、FⅦc、PAI-1均显著增高(P<0.01),t-PA明显下降(P<0.01);正常妊娠组AT-Ⅲ较非孕组呈下降趋势,GDM患者AT-Ⅲ水平、PCAT与正常妊娠组无显著差异。全部GDM患者GHbA1c与t-PA呈负相关(r=-0.607,P<0.01),与PAI-1呈正相关(r=0.493,P<0.01),与FⅦc活性正相关(r=0.421,P<0.01)。结论糖尿病孕妇存在着明显的血栓前状态,血糖通过影响纤溶凝血系统功能,导致凝血功能异常,在妊娠糖尿病的发生发展中起着重要的作用。提示应密切关注患者糖化血红蛋白及凝血纤溶指标的变化,预防并发症的发生。 Objective To study the changes of coagulation function and fibrinolytic system in patients with gestational diabetes mellitns (GDM), and to investigate the correlation between GHbA1c and the index. Method Forty non-pregnant women, 40 with normal pregnancy and 50 with GDM were enrolled in this study for the examinations of GHbA1c, activity of Coagulation FactorⅦc, tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor (PAI-1), antithrombin m (AT-Ⅲ) and ProC. Result GHbA1c, FⅦc and PAI-1 were significantly elevated while t-PA was lower in GDM patients when compared with the non-pregnant women and women with normal pregnancy (P〈0.01). AT-Ⅲ and ProC measurement showed no significant differences between GDM patients and women in the normal pregnancy group. There were positive correlations between the level of GHbA1c and activity of F Ⅶ c and PA I-1 in GDM patients. However the level of GHbA1c was negatively correlated with t-PA activity. Conclusion GDM women have the state of significant hypercoagnlation. Serum GHbA1c may play an important role in the pathogenesis of GDM by inducing coagulative and fihrinolytic dysfunctions. The detection of blood fibrinolyic activity and the coagulation function can be useful for prevention of complications of GDM.
出处 《热带医学杂志》 CAS 2009年第8期905-907,共3页 Journal of Tropical Medicine
关键词 妊娠期糖尿病 糖化血红蛋白A 血浆凝血因子Ⅶc 组织纤溶酶原激活物 纤溶酶原激活物 抑制物-1 gestational diabetes mellitus glycosylated factor Ⅶ tissue plasminogen activators plasminogen activator inhibitor 1
  • 相关文献

参考文献6

  • 1何莲珠,陈萍,伍风群,姜卉.城乡孕妇妊娠期糖尿病筛查结果分析[J].热带医学杂志,2006,6(11):1167-1169. 被引量:3
  • 2Ananth CV. Epidemiologic approaches for studying recurrent pregnancy outcomes: challenges and implications for research [ J ]. Semin Perinatol, 2007,31 ( 3 ) : 175-176.
  • 3Hollander MH, Parlbeg KM, Huisjes AJ. Gestational diabetes: a review of the current literature and guidelines [J]. Obstet Gyneeol Surv, 2007,62(2) : 125-136.
  • 4Mora-Janiszewska O, Kulik-Rechberger B, Rechberger T. The role of insulin resistance and resistin in pathogenesis of diabetes mellitus with special attention to diabetes in pregnancy [ J ]. Ginekol Pol, 2005,76 (7) : 580-585.
  • 5Koh H, Akiyama Y, Yui K, et al. Effect of troglitazone on serum gamma-glutamyl- transferase activity and plasma t-PA / PA I21 complex in type 2 diabetic patients [J]. Arzneimitte- lforschung, 2006,56(4) : 288-294.
  • 6Natali A, Toschi E, Baldeweg S, et al. Clustering of insulin resistance with vascular dysfunction and low2grade inflammation in type 2 diabetes [J]. Diabetes, 2006,55(4):1133-1140.

二级参考文献9

共引文献2

同被引文献14

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部